Neuralink, Elon Musk's brain implant venture, is reaching out to major U.S. neurosurgery centers to potentially begin testing its devices on humans, according to a Reuters report. Before that can happen though, the U.S. government needs to grant the company approval, which is far from certain. In 2022, the U.S. Food and Drug Administration rejected its application to proceed with human trials due to safety concerns. Neuralink has been working to address those concerns ever since. 

Share:
More In Science
Cases of HMPV Respiratory Virus Spiked This Spring
You've probably heard about respiratory viruses like RSV and the flu, but now doctors are saying a new virus is on the rise. Cases of human metapneumovirus, or HMPV, spiked this spring, according to the CDC. The virus causes many of the same symptoms as the flu , including coughing, runny nose, sore throat, and fever.
Load More